BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25561020)

  • 1. Utilisation of preoperative imaging for muscle-invasive bladder cancer: a population-based study.
    McInnes MD; Siemens DR; Mackillop WJ; Peng Y; Wei S; Schieda N; Booth CM
    BJU Int; 2016 Mar; 117(3):430-8. PubMed ID: 25561020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological factors associated with survival benefit from adjuvant chemotherapy (ACT): a population-based study of bladder cancer.
    Booth CM; Siemens DR; Wei X; Peng Y; Berman DM; Mackillop WJ
    BJU Int; 2015 Sep; 116(3):373-81. PubMed ID: 25168574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study.
    Booth CM; Siemens DR; Li G; Peng Y; Tannock IF; Kong W; Berman DM; Mackillop WJ
    Cancer; 2014 Jun; 120(11):1630-8. PubMed ID: 24733278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
    Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
    Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study.
    Booth CM; Siemens DR; Li G; Peng Y; Kong W; Berman DM; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):506-14. PubMed ID: 24954284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processes of care and the impact of surgical volumes on cancer-specific survival: a population-based study in bladder cancer.
    Siemens DR; Mackillop WJ; Peng Y; Berman D; Elharram A; Rhee J; Booth CM
    Urology; 2014 Nov; 84(5):1049-57. PubMed ID: 25443899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study.
    Leveridge MJ; Siemens DR; Mackillop WJ; Peng Y; Tannock IF; Berman DM; Booth CM
    Urology; 2015 Apr; 85(4):791-8. PubMed ID: 25661830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume.
    Goossens-Laan CA; Visser O; Hulshof MC; Wouters MW; Bosch JL; Coebergh JW; Kil PJ
    BJU Int; 2012 Jul; 110(2):226-32. PubMed ID: 22044615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.
    May M; Burger M; Brookman-May S; Stief CG; Fritsche HM; Roigas J; Zacharias M; Bader M; Mandel P; Gilfrich C; Seitz M; Tilki D
    Clin Genitourin Cancer; 2014 Aug; 12(4):278-86. PubMed ID: 24331576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
    Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
    BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    Patel MI; Bang A; Gillatt D; Smith DP
    BJU Int; 2015 Oct; 116 Suppl 3():18-25. PubMed ID: 26334934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of pre-operative imaging for colon cancer: A population-based study.
    McInnes MD; Nanji S; Mackillop WJ; Flemming JA; Wei X; Macdonald DB; Scheida N; Booth CM
    J Surg Oncol; 2017 Feb; 115(2):202-207. PubMed ID: 27813103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base.
    Smith AB; Deal AM; Woods ME; Wallen EM; Pruthi RS; Chen RC; Milowsky MI; Nielsen ME
    BJU Int; 2014 Nov; 114(5):719-26. PubMed ID: 24325202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
    Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F; Fujii Y; Masuda H; Numao N; Yokoyama M; Ishioka J; Saito K; Kawakami S; Kihara K
    BJU Int; 2012 Sep; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
    Fairey AS; Jacobsen NE; Chetner MP; Mador DR; Metcalfe JB; Moore RB; Rourke KF; Todd GT; Venner PM; Voaklander DC; Estey EP
    J Urol; 2009 Jul; 182(1):85-92; discussion 93. PubMed ID: 19447413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
    Koga F; Kihara K; Yoshida S; Yokoyama M; Saito K; Masuda H; Fujii Y; Kawakami S
    BJU Int; 2012 Mar; 109(6):860-6. PubMed ID: 21854531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.